Human milk oligosaccharide associated with the firmicutes-to-bacteroidetes ratio among stunted infants in Malang, Indonesia.

IF 1.5 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Annisa Annisa, Sanarto Santoso, Lilik Zuhriyah, Dian Handayani
{"title":"Human milk oligosaccharide associated with the firmicutes-to-bacteroidetes ratio among stunted infants in Malang, Indonesia.","authors":"Annisa Annisa, Sanarto Santoso, Lilik Zuhriyah, Dian Handayani","doi":"10.4149/BLL_2024_94","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Human milk oligosaccharide (HMO) is a unique component of breastmilk. To date, no study has investigated the correlation between HMO and infant nutritional status particularly through the lens of gut microbiota. Therefore, our study aims to investigate the relationships between 2'-Fucosyllactose (2'-FL) in HMO and Firmicutes/Bacteroidetes (F/B) ratio among stunted infants.</p><p><strong>Methods: </strong>A case-control study was conducted among 103 mother-infant pairs in Malang City, Indonesia. The quantification of 2'-FL HMO was assessed using High-Performance Liquid Chromatography (HPLC). The F/B ratio was analyzed with real-time poly-chain reaction (RT-PCR). For bivariate analysis, we employed the Spearman correlation and Mann‒Whitney tests, while for multivariate analysis, we utilized multiple linear regression.</p><p><strong>Results: </strong>The findings showed that the stunted nutritional status was detected in 49 out of 103 infants. In this group, 40.81% of mothers of infants with a stunted nutritional status had a secretor-positive status, while all mothers of infants with appropriate nutritional status tested positive for the secretor status (100%). However, the association between maternal secretor status and infant nutritional status was not statistically significant (p>0.05). The average levels of 2'-FL HMO in breast milk were lower in the group with stunted infants compared to non-stunted infants (1.21 mg/L vs 1.40 mg/L). The regression analysis revealed a significant association of 2'-FL HMO levels with the presence of Bacteroidetes and value of the F/B ratio (p>0.05).</p><p><strong>Conclusions: </strong>The breast milk component 2'-FL HMO significantly influences the gut microbiota of stunted infants. Future research aimed at elucidating the mechanisms by which 2'-FL HMO modulates infant gut microbiota should consider not only concentration and specific bacterial taxa but also intake levels (Tab. 2, Fig. 1, Ref. 37). Text in PDF www.elis.sk Keywords: 2'-fucosyllactose, human milk, oligosaccharide, firmicutes, bacteroidetes, stunting, infant.</p>","PeriodicalId":55328,"journal":{"name":"Bratislava Medical Journal-Bratislavske Lekarske Listy","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bratislava Medical Journal-Bratislavske Lekarske Listy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4149/BLL_2024_94","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Human milk oligosaccharide (HMO) is a unique component of breastmilk. To date, no study has investigated the correlation between HMO and infant nutritional status particularly through the lens of gut microbiota. Therefore, our study aims to investigate the relationships between 2'-Fucosyllactose (2'-FL) in HMO and Firmicutes/Bacteroidetes (F/B) ratio among stunted infants.

Methods: A case-control study was conducted among 103 mother-infant pairs in Malang City, Indonesia. The quantification of 2'-FL HMO was assessed using High-Performance Liquid Chromatography (HPLC). The F/B ratio was analyzed with real-time poly-chain reaction (RT-PCR). For bivariate analysis, we employed the Spearman correlation and Mann‒Whitney tests, while for multivariate analysis, we utilized multiple linear regression.

Results: The findings showed that the stunted nutritional status was detected in 49 out of 103 infants. In this group, 40.81% of mothers of infants with a stunted nutritional status had a secretor-positive status, while all mothers of infants with appropriate nutritional status tested positive for the secretor status (100%). However, the association between maternal secretor status and infant nutritional status was not statistically significant (p>0.05). The average levels of 2'-FL HMO in breast milk were lower in the group with stunted infants compared to non-stunted infants (1.21 mg/L vs 1.40 mg/L). The regression analysis revealed a significant association of 2'-FL HMO levels with the presence of Bacteroidetes and value of the F/B ratio (p>0.05).

Conclusions: The breast milk component 2'-FL HMO significantly influences the gut microbiota of stunted infants. Future research aimed at elucidating the mechanisms by which 2'-FL HMO modulates infant gut microbiota should consider not only concentration and specific bacterial taxa but also intake levels (Tab. 2, Fig. 1, Ref. 37). Text in PDF www.elis.sk Keywords: 2'-fucosyllactose, human milk, oligosaccharide, firmicutes, bacteroidetes, stunting, infant.

人乳寡糖与印尼玛琅发育迟缓婴儿中坚固菌与类杆菌比例的关系。
背景:母乳低聚糖(HMO)是母乳中的一种独特成分。迄今为止,还没有研究调查过 HMO 与婴儿营养状况之间的相关性,特别是通过肠道微生物群的视角。因此,我们的研究旨在调查 HMO 中的 2'-Fucosyllactose (2'-FL) 与发育迟缓婴儿中的固醇菌/类杆菌 (F/B) 比率之间的关系:方法:对印度尼西亚玛琅市的 103 对母婴进行了病例对照研究。采用高效液相色谱法(HPLC)评估了 2'-FL HMO 的定量。实时多链反应(RT-PCR)分析了F/B比值。在双变量分析中,我们采用了斯皮尔曼相关检验和曼-惠特尼检验;在多变量分析中,我们采用了多元线性回归:结果:研究结果显示,103 名婴儿中有 49 名营养不良。在这组婴儿中,40.81%营养不良婴儿的母亲分泌物呈阳性,而所有营养状况正常婴儿的母亲分泌物检测均呈阳性(100%)。然而,母体分泌物状态与婴儿营养状况之间的关系没有统计学意义(P>0.05)。与非发育迟缓婴儿相比,发育迟缓婴儿组母乳中 2'-FL HMO 的平均水平较低(1.21 mg/L vs 1.40 mg/L)。回归分析表明,2'-FL HMO 含量与类杆菌的存在和 F/B 比值有明显关系(P>0.05):结论:母乳成分 2'-FL HMO 对发育迟缓婴儿的肠道微生物群有重大影响。未来旨在阐明 2'-FL HMO 调节婴儿肠道微生物群机制的研究不仅应考虑浓度和特定细菌类群,还应考虑摄入量(表 2,图 1,参考文献 37)。PDF 格式的文本 www.elis.sk 关键词:2'-岩藻糖 人乳 寡糖 坚球菌 类杆菌 发育迟缓 婴儿
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.60
自引率
0.00%
发文量
185
审稿时长
3-8 weeks
期刊介绍: The international biomedical journal - Bratislava Medical Journal – Bratislavske lekarske listy (Bratisl Lek Listy/Bratisl Med J) publishes peer-reviewed articles on all aspects of biomedical sciences, including experimental investigations with clear clinical relevance, original clinical studies and review articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信